31 Aug 2010
Clariant addresses change control with new pharmaceutical brand at ICSE 2010
Muttenz, August 31, 2010 - Clariant, the trusted, and one of the leading global providers of color and surface engineered materials, will unveil its new brand of masterbatches and compounds for pharmaceutical and medical applications for the first time at ICSE 2010 (Booth 4E110, 5-7 October, Paris).
The new, sector-dedicated brand will reflect Clariant’s commitment to help minimize the impact of change and support the need for reliability and consistency in materials used for pharmaceutical packaging and medical devices. Such control of risk in a pharmaceutical product’s development and lifecycle is increasingly relevant in light of tightening regulatory requirements governing end-product ingredients.
Show visitors will be the first to discover how Clariant's controlled, compliant and consistent products deliver color and functionality and help to minimize the risks and costs of non-compliance.
The new brand will be produced at Clariant’s three centers of competence dedicated to the production of specialty formulated masterbatches and compounds for medical and pharmaceutical applications. The company is expecting to achieve full ISO 13485:2003 accreditation, having already gained accreditation for two out of the three sites. Located in the United States, Europe and Asia, they offer manufacturing-line segregation to reduce risk of cross contamination between products. Consistency and reliability of formulations and procedures is assured through alignment with the globally harmonized quality management system.
Highlights on show at ICSE 2010 include a range of newly introduced globally harmonized standard colors for PP and PE as well as PEBA, where ingredients have been biologically evaluated according to ISO10993 and USP parts 87 and 88 (Class VI). Surface engineering such as laser marking and friction reduction provide another aspect to Clariant’s offerings at the show.
Clariant’s product solutions cover a wide range of polymers and thermoplastic elastomers including PE, PP, ABS, SAN, PC/ABS, PC, PA6, 66 and 12, high performance polymers, and elastomers such as EVA. SEBS, TPU, Hytrel® and PEBA. Visitors from the pharmaceutical packaging sector will be interested to note solutions for PP, HDPE and PETG. Device producers will see Clariant’s wide portfolio including materials used in invasive devices such as ISO 10993 / USP Class VI products based on PEBA.
“The new brand is our recognition that the medical and pharma industry requires something different to our customers in lower risk segments,” comments Steve Duckworth, Head of Global Market Segment Consumer Goods & Medical at Clariant. “It is not just about clearly identifying the products that meet the latest trends for functionality and aesthetics in this industry but encapsulates the whole package of dedicated service and expertise, reliability and innovative material performance that gives the industry the confidence it needs to address risk potential.”
For more information visit Clariant at Booth 4E110.
Clariant International will exhibit its new process solvents for organic synthesis alongside Clariant’s leading ranges of versatile molecules for Intermediates, Glymes®, Butyl Glymes and Polyglykols® for the pharmaceutical sector at Booth 6L62 in Hall 6 at the concurrent CPhI event at the Paris Nord Villepinte from October 5-7, 2010.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant – Exactly your chemistry
Clariant is a global leader in the field of specialty chemicals. Strong business relationships, commitment to outstanding service and wide-ranging application know-how make Clariant a preferred partner for its customers.
Clariant, which is represented on five continents with over 100 group companies, employs around 17,300 people. Headquartered in Muttenz near Basel, Switzerland, it generated sales of CHF 6.6 billion in 2009. Clariant is organized into ten Business Units: Additives; Detergents & Intermediates; Emulsions; Industrial & Consumer Specialties; Leather Services; Masterbatches; Oil & Mining Services; Paper Specialties; Pigments; and Textile Chemicals.
Clariant is committed to sustainable growth, which is derived from its own innovative strength. Clariant’s world-class products and services play a key role in its customers’ manufacturing processes and add value to their end products. The company’s success is based on the know-how of its people and their ability to identify new customer needs at an early stage and to work together with customers to develop innovative, efficient solutions.
Hytrel is a registered trademark of DuPont.
Glymes and Polyglykols are registered trademarks of Clariant.
Related images
Clariant, the trusted, and one of the leading global providers of color and surface engineered materials, will unveil its new brand of masterbatches and compounds for pharmaceutical and medical applications for the first time at ICSE 2010.
(Photo: Clariant)
Editorial enquiries
Stefanie Nehlsen
Clariant International Ltd
stefanie.nehlsen@clariant.com
Paulien Boumans
EMG